The impact of pre-intervention rate of kidney function change on the assessment of CKD progression.

CONCLUSION: Most patients (>60 %) entering this clinical trial had stable or improving kidney function. Enrolment was associated with further improved kidney function, which may have been due to 'regression to the mean' or to the Hawthorne effect. Investigators should include a run-in period to establish the presence of eGFR decline to use as an inclusion criterion in clinical trials assessing this measure of CKD progression.
PMID: 24504906 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)